Celltrion
068270.KS
#816
Rank
โ‚น2.565 T
Marketcap
โ‚น11,406
Share price
-0.53%
Change (1 day)
20.12%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น90.55

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น96.46. In 2023 the company made an earnings per share (EPS) of โ‚น249.48 a decrease over its 2022 EPS that were of โ‚น254.78.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น90.55
2023โ‚น249.48-2.08%
2022โ‚น254.78-11.72%
2021โ‚น288.602.03%
2020โ‚น282.8582.8%
2019โ‚น154.7318.31%
2018โ‚น130.78-36.33%
2017โ‚น205.42161.25%
2016โ‚น78.632.86%
2015โ‚น76.4417.84%
2014โ‚น64.875.87%
2013โ‚น61.27-70.85%
2012โ‚น210.20134.09%
2011โ‚น89.7943.59%
2010โ‚น62.5474.49%
2009โ‚น35.84317.8%
2008โ‚น8.58-71.7%
2007โ‚น30.31